Pharmacological inhibition of LSD1 for cancer treatment

GJ Yang, PM Lei, SY Wong, DL Ma, CH Leung - Molecules, 2018 - mdpi.com
Lysine-specific demethylase 1A (LSD1, also named KDM1A) is a demethylase that can
remove methyl groups from histones H3K4me1/2 and H3K9me1/2. It is aberrantly expressed …

The heterogeneity of prostate cancers lacking AR activity will require diverse treatment approaches

MP Labrecque, JJ Alumkal, IM Coleman… - Endocrine-related …, 2021 - erc.bioscientifica.com
The use of androgen deprivation therapy and second line anti-androgens in prostate cancer
has led to the emergence of tumors employing multiple androgen receptor (AR)-dependent …

KRT6A promotes lung cancer cell growth and invasion through MYC-regulated pentose phosphate pathway

D Che, M Wang, J Sun, B Li, T Xu, Y Lu… - Frontiers in Cell and …, 2021 - frontiersin.org
Keratin 6A (KRT6A) belongs to the keratin protein family which is a critical component of
cytoskeleton in mammalian cells. Although KRT6A upregulation in non-small cell lung …

Clinical activity of CC‐90011, an oral, potent, and reversible LSD1 inhibitor, in advanced malignancies

A Hollebecque, S Salvagni, R Plummer, P Niccoli… - Cancer, 2022 - Wiley Online Library
Background CC‐90011 is an oral, potent, selective, reversible inhibitor of lysine‐specific
demethylase 1 (LSD1) that was well tolerated, with encouraging activity in patients who had …

Mechanisms of carcinogenic activity triggered by lysine-specific demethylase 1A

C Yang, D Li, S Zang, L Zhang, Z Zhong… - Frontiers in …, 2022 - frontiersin.org
Epigenetics has emerged as a prime focus area in the field of cancer research. Lysine-
specific demethylase 1A (LSD1), the first discovered histone demethylase, is mainly …

Alternative splicing of LSD1+ 8a in neuroendocrine prostate cancer is mediated by SRRM4

DJ Coleman, DA Sampson, A Sehrawat… - Neoplasia, 2020 - Elsevier
Neuroendocrine prostate cancer (NEPC) is the most virulent form of prostate cancer.
Importantly, our recent work examining metastatic biopsy samples demonstrates NEPC is …

[HTML][HTML] Sanguinarine, identified as a natural alkaloid LSD1 inhibitor, suppresses lung cancer cell growth and migration

T Qin, Z Li, L Li, K Du, J Yang, Z Zhang… - Iranian Journal of …, 2022 - ncbi.nlm.nih.gov
Objective (s): Lysine-specific demethylase1 (LSD1), an important class of histone
demethylases, plays a crucial role in regulation of mammalian biology. The up-regulated …

Histone lysine specific demethylase 1 inhibitors

S Mehndiratta, JP Liou - RSC Medicinal Chemistry, 2020 - pubs.rsc.org
LSD1 plays a pivotal role in numerous biological functions. The overexpression of LSD1 is
reported to be associated with different malignancies. Over the last decade, LSD1 has …

Genes diferencialmente expresados en cáncer de pulmón de células pequeñas: Potenciales dianas terapéuticas

LE Jiménez Sánchez - 2024 - digibug.ugr.es
Introducción: El cáncer de pulmón de células pequeñas (SCLC, por sus siglas en inglés) se
caracteriza por una expectativa de vida desalentadora y una limitación en las opciones de …

Targeting LSD1 for direct effects and induction of anti-tumor immunity against lethal prostate cancer

TEG Krueger - 2021 - jscholarship.library.jhu.edu
Abstract Lysine-specific demethylase 1 (LSD1 or KDM1A) is overexpressed in numerous
cancers and is emerging as a critical mediator of tumor progression. Though well …